Tiagem^®

Gemcitabine

Product Information

Proprietary Name: Tiagem®
Generic Name: Gemcitabine
Dosage Form: Vial
Strengths: 200 mg/2 ml, 1000 mg/10 ml
Indications: Ovarian Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Bladder Cancer

Oncology

Gemcitabine is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.